---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-011475"
form_type: "8-K"
ticker: "ZTS"
cik: "0001555280"
company_name: "Zoetis Inc."
filed_at: "2023-02-07T23:59:59+00:00"
generated_at: "2026-06-19T22:51:44.255160+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Zoetis fires EVP Glenn David for undisclosed relationship; interim head named

## Summary
- Glenn David, EVP and Group President of U.S. Operations and Global Diagnostics, terminated Feb 5 for violating company policy (consensual personal relationship, failure to disclose).
- David forfeits severance benefits and future equity vesting as a result of termination for cause.
- William ('Chip') Dorsey, VP Finance, named interim head of U.S. Operations and Global Diagnostics; permanent search underway.
- Company states conduct did not impact consolidated financial statements or internal controls over financial reporting.

## SEC filing metadata
- accession: 0001104659-23-011475
- form_type: 8-K
- ticker: ZTS
- cik: 0001555280
- company_name: Zoetis Inc.
- filed_at: 2023-02-07T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1555280/000110465923011475/0001104659-23-011475-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1555280/000110465923011475/tm235694d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-011475
- JSON: https://secwatch.observer/filing/0001104659-23-011475.json
- Plain text: https://secwatch.observer/filing/0001104659-23-011475.txt

## Key facts
- Executive change
  Glenn David was terminated as Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices at Zoetis Inc..
  - Action: terminated
  - Role: Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices
  source text: On February 5, 2023, Zoetis terminated Glenn David, Executive Vice President and Group President, U.S. Operations, Global Diagnostics and BioDevices at Zoetis Inc. (the “Company”), for violating company policy by engaging in a consensual personal relationship and failing to disclose it to the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1555280/000110465923011475/0001104659-23-011475-index.htm
- Executive change
  William Dorsey was appointed as interim head of U.S. Operations and Global Diagnostics at Zoetis Inc..
  - Action: will serve as interim head
  - Role: interim head of U.S. Operations and Global Diagnostics
  source text: William (“Chip”) Dorsey, Vice President, Finance will serve as interim head of U.S. Operations and Global Diagnostics while the Company conducts a search for Mr. David’s permanent replacement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1555280/000110465923011475/0001104659-23-011475-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.